Welcome to the e-CCO Library!

P797: Crohn’s disease and ulcerative colitis was associated with different lipid profile disorders: a nationwide population-based study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Soh*1, J. Chun1, K. Han2, S. Park1, E. A. Kang1, J. P. Im1, J. S. Kim1

Created: Friday, 22 February 2019, 9:41 AM
P797: Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with Inflammatory Bowel Disease: Results of a multicenter survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bikar, A.(1);Farkas, N.(2);Resál, T.(3);Szepes, Z.(3);Klaudia, F.(3);Vincze, Á.(1);Miheller, P.(4);Molnár , T.(3);Sarlós, P.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P798 Societal costs attributable to Crohn’s disease and ulcerative colitis within the first 5 years after diagnosis: –a Danish Nationwide Cost-of-Illness Study 2003–2015
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. ALULIS1, K. Vadstrup2, A. Borsi3, S. Elkjær Stallknecht4, J. Olsen4, T. Rikke Jørgensen5, C. Wennerström6, N. Qvist7, P. Munkholm8

Created: Thursday, 30 January 2020, 10:12 AM
P798: Quality of sexual life in patients with ulcerative colitis: a monocentric observational study. On behalf of IG-IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Di Fluri*1, A. Tongiorgi1, C. Caudai2, M. G. Mumolo1, G. Laino3, N. De Bortoli3, G. Tapete3, E. Albano3, L. Bertani3, G. Baiano Svizzero3, S. Marchi3, F. Costa1, L. Ceccarelli1

Created: Friday, 22 February 2019, 9:41 AM
P798: The experience of inflammatory bowel disease patients with health care in Spain: Insights from the IEXPAC project
Year: 2018
Source: ECCO '18 Vienna
Authors:

I. Marín-Jiménez1*, F. Casellas2, B. Juliá3, L. Cea-Calvo3

Created: Thursday, 21 February 2019, 9:14 AM
P798: Understanding anti-TNF treatment failure: mechanisms and management of loss of response to anti-TNF therapy, three-year data from the PANTS study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Chanchlani, N.(1)*;Lin, S.(1);Hamilton, B.(1);Bewshea, C.(1);Thomas, A.(1);Smith, R.(1);Roberts, C.(1);Nice, R.(2);McDonald, T.J.(2);Goodhand, J.R.(1);Ahmad, T.(1);Kennedy, N.A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P799 Use of anti-TNF agents may reduce a risk of venous thromboembolism in Korean patients with inflammatory bowel disease: A nationwide population-based study from the National Health Insurance Database
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H.M. Kim1, S.Y. Kim2, H.S. Kim2, J.K. Lee3, S.H. Park3, J.S. Moon3, Y.S. Cho4, D.R. Kang3

Created: Thursday, 30 January 2020, 10:12 AM
P799: Frequency of vaccination for herpes zoster (HZ) among inflammatory bowel disease (IBD) patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Trivedi1, H. Kavani1, N. Khan1,2*

Created: Thursday, 21 February 2019, 9:14 AM
P799: Infliximab and immunomodulator combination therapy in inflammatory bowel disease – no longer inseparable?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Carlson, S.(1)*;Evgeniou, V.(1);Kok, K.(1);
Created: Friday, 14 July 2023, 11:12 AM
P799: Perinatal factors and development of IBD: a national case–control study with nearly 50 years of follow-up: report from the epiIIRN database
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Velosa*1, B. Yerushalmi2, N. Asayag1, G. Focht1, D. Navon1, H. Hochner3, Y. Friedlander3, I. Brufman4, B. Feldman4, R. D. Balicer4, A. Cahan5, N. Ledderman6, E. Matz7, I. Peter8, D. Turner1

Created: Friday, 22 February 2019, 9:41 AM
P800 Treatment patterns for biologics in ulcerative colitis and Crohn’s disease: A Danish Nationwide Register Study from 2003 to 2015
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Alulis1, K. Vadstrup2, A. Borsi3, A. Nielsen4, T. Rikke Jørgensen5, N. Qvist6, P. Munkholm7

Created: Thursday, 30 January 2020, 10:12 AM
P800: Factors related to non-adherence behaviours of patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Marín-Jiménez*1, F. Casellas2, M. F. García-Sepulcre3, E. Navarro-Correal2, B. Juliá4, N. Soto4, L. Cea-Calvo5

Created: Friday, 22 February 2019, 9:41 AM
P800: Five-year prospective follow-up of paediatric IBD patients based on HUPIR (Hungarian paediatric IBD registry)
Year: 2018
Source: ECCO '18 Vienna
Authors:

K.E. Müller1*, HUPIR Group, G. Veres2

Created: Thursday, 21 February 2019, 9:14 AM
P800: Upadacitinib is effective and safe for Crohn's Disease: prospective real-world experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Friedberg, S.(1)*;Choi, D.(1);Hunold, T.(1);Choi, N.K.(1);Garcia, N.M.(1);Picker, E.A.(1);Cohen, N.A.(1);Cohen, R.D.(1);Dalal, S.R.(1);Pekow, J.(1);Sakuraba, A.(1);Cleveland, N.K.(1);Rubin, D.T.(1);
Created: Friday, 14 July 2023, 11:12 AM
P801 Treatment patterns of complex perianal fistula in Crohn’s disease in five European countries: the PREFACE study, a retrospective chart review
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Ferrante1, L. Siproudhis2, G. Poggioli3, M. Reinshagen4, S. Milicevic5, M. Roset6, B. Thun7, N. Bent-Ennakhil8, R. D′Ambrosio8, A. Fernandez-Nistal5, J. Panes9

Created: Thursday, 30 January 2020, 10:12 AM
P801: Maintenance phase effectiveness and persistence after two years in biologic-naïve ulcerative colitis patients treated with vedolizumab or anti-TNF (VEDO-IBD-study)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Plachta-Danielzik, S.(1);Bokemeyer, B.(1,2,3)*;Efken, P.(4);Mohl, W.(5);Krause, T.(6);Hoffstadt, M.(7);Ehehalt, R.(8);Trentmann, L.(9);Schweitzer, A.(10);Jessen, P.(11);Franzenburg, S.(1);Hartmann, P.(4);di Giuseppe, R.(1);Schreiber, S.(1,3);
Created: Friday, 14 July 2023, 11:12 AM
P801: Physicians’ knowledge and application of immunisation strategies in patients with inflammatory bowel disease: a survey by the Italian Group for the study of inflammatory bowel disease (IG-IBD)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. S. Macaluso*1, G. Mazzola2, M. Ventimiglia1, P. Alvisi3, S. Renna1, L. Adamoli2, M. Galli4, A. Armuzzi5, S. Ardizzone6, A. Cascio2, M. Cottone1, A. Orlando1

Created: Friday, 22 February 2019, 9:41 AM
P801: Trends in inflammatory bowel disease incidence in Korea: A nationwide population-based study 2004–2015
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Lee1, S.Y. Shin2*, J.J. Park2, J.H. Cheon3, T.I. Kim3, H. Park2, W.H. Kim3, A.S. Shin1

Created: Thursday, 21 February 2019, 9:14 AM
P802 Probability of vedolizumab response as defined by clinical decision support tool is associated with lower healthcare utilisation in patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Dulai1, Y. Wan2, Z. Huang2, M. Luo2

Created: Thursday, 30 January 2020, 10:12 AM
P802: Perforating Crohn's Disease and pancolitis as risk factors for incident cancer: a prospective multi-centre nested case–control IG-IBD study at 6 years
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Petruzziello1, A. Armuzzi2, M. L. Scribano3, F. Castiglione4, R. D'incà5, M. Daperno6, C. Papi7, M. Vecchi8, W. Fries9, G. Riegler10, P. Alvisi11, F. Mocciaro12, B. Neri13, S. Festa7, A. Testa14, E. Calabrese15, R. Di Mitri16, E. De Crstofaro1, C. Gesuale1, L. Spina17, F. Rogai18, S. Renna19, G. Meucci20, L. Guidi21, A. Rossi15, A. Orlando19, L. Biancone*15

Created: Friday, 22 February 2019, 9:41 AM